SCHEMBL304764

SCHEMBL304764

O=C1COc2ccc(-c3ccccc3)cc2N1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.62
ALDH1A1 P00352 4/20 0.62
KMT2A Q03164 2/20 0.62
HPGD P15428 2/20 0.62
KDM4E B2RXH2 2/20 0.62
MMP12 P39900 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
NR3C2 P08235 4/20 0.59
AKT1 P31749 1/20 0.59
AKT2 P31751 1/20 0.59
AKT3 Q9Y243 1/20 0.59
PARP1 P09874 3/20 0.58
GAA P10253 1/20 0.56
NR3C1 P04150 2/20 0.55
PGR P06401 2/20 0.55
AR P10275 1/20 0.55
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
LMNA P02545 1/20 0.53
PDE3B Q13370 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19188055 0.86 MMP12 (0.77) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4292625 0.86 NR3C2 (0.81) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4290476 0.86 NR3C2 (0.73) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4267366 0.85 MMP12 (0.70) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL5214057 0.84 ALDH1A1 (0.60) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4259329 0.83 PARP1 (0.65) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4267784 0.83 PKM (0.59) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4264682 0.83 MMP12 (0.58) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4934583 0.82 PARP1 (0.53) MAPTALDH1A1KMT2AHPGDKDM4E
SCHEMBL4269390 0.82 NR3C2 (0.52) MAPTALDH1A1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US claimed
JP-2008508314-A 2008-03-21 JP claimed
EP-1778242-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2007-05-02 EP claimed
WO-2006015259-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2006-02-09 WO claimed
US-8093238-B2 Fused thiazole derivatives as kinase inhibitors UCB PHARMA S.A. (BE) 2012-01-10 US disclosed
US-20100069361-A1 Fused Thiazole Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-03-18 US disclosed
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US disclosed
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069361-A1 Fused Thiazole Derivatives as Kinase Inhibitors JAK1, MTOR, MOK MAPT 1997/4885ALDH1A1 1714/4885KMT2A 3107/4885
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS NR5A1, ESRRA, NR3C1 MAPT 3273/4885ALDH1A1 3483/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.